Leaflet FOSTER NEXTHALER 100mcg / 6mcg / dose inhalation powder


Indicated for: asthma; chronic obstructive pulmonary disease

Route of administration: inhalation

Substance: beclomethasone + formoterol (bronchodilator + beta-2 adrenergic agonist)

ATC: R03AK08 (Respiratory system | Adrenergics, inhalants | Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics)

Precautions:
Hyperglycemia
Hyperglycemia

This medicine may increase blood sugar.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Cardiac risk / QT prolongation / arrhythmias
Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.

Beclometasone + formoterol is a combination of a corticosteroid and a long-acting beta-agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Beclometasone reduces airway inflammation, while formoterol relaxes the smooth muscles of the bronchi, improving airflow.

This combination is administered as an inhaler, usually twice daily, as maintenance therapy to prevent symptoms and exacerbations. It is indicated for patients requiring both inflammation control and bronchodilation.

Common side effects include throat irritation, hoarseness, tremors, and palpitations. In rare cases, severe adverse reactions such as paradoxical bronchospasm or hypokalemia may occur. It is important for patients to follow the prescribed dosage and use the inhaler correctly to maximize treatment benefits.

Beclometasone + formoterol is an effective therapeutic option for managing chronic respiratory diseases, contributing to improved quality of life for patients.

General data about FOSTER NEXTHALER 100mcg / 6mcg / dose

  • Substance: beclomethasone + formoterol
  • Date of last drug list: 01-06-2026
  • Commercial code: W60547004
  • Concentration: 100mcg / 6mcg / dose
  • Pharmaceutical form: inhalation powder
  • Quantity: 1
  • Product type: original
  • Price: 207.71 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: CHIESI FARMACEUTICI S.P.A. - ITALIA
  • Holder: CHIESI PHARMACEUTICALS GMBH - AUSTRIA
  • Number: 11577/2019/04
  • Shelf life: 3 years-after packing for marketing;after the first opening a pungii-6 months

Pharmaceutical forms available for beclomethasone + formoterol

Concentrations available for beclomethasone + formoterol

  • 100mcg/6mcg/dose
  • 200mcg/12mcg
  • 200mcg/6mcg
  • 200mcg/6mcg/dose

Compensation lists for FOSTER NEXTHALER 100mcg / 6mcg / dose Chiesi

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

207.71 RON

96.41 RON

111.31 RON